J Adv Res (2017) 8(5):48793
Our expert team takes a personalized approach to care, tailoring treatments to meet your unique needs and goals
Semaglutide, tirzepatide, and the investigational triple agonist retatrut Orforglipron (developmental code LY3502970, brand name Foundayo) is the first orally administered, small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist to reach late-st The question of how Melanotan II modulates melanocortin 1 receptor (MC1R) signaling sits at the intersection of receptor pharmacology and pigment biology
Publicly available, expert-validated training datasets are virtually non-existent, compelling individual laboratories to generate costly labeled data
Some obesity medicine specialists suggest higher intakes for specific populations, particularly patients who are physically active, older adults at higher risk for sarcopenia, or those losing weight rapidly